Hydrocele & Spermatocele
Benign Scrotal Fluid Collections and Sperm-Filled Cysts
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (benign, often observed)
Reference only. Not medical advice.
What can go wrong
A new or enlarging scrotal mass must be evaluated by ultrasound to exclude testicular tumor before it is dismissed as a hydrocele - a tense hydrocele can obscure an underlying cancer. Aspiration alone tends to recur; sclerotherapy improves durability but can cause pain and inflammation. Surgery carries hematoma and infection risk and, for spermatocelectomy, epididymal obstruction.
This is something to take to a clinician. The Atlas can tell you what is known about hydrocele & spermatocele in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
A hydrocele is a collection of serous fluid within the tunica vaginalis around the testis; a spermatocele (spermatic cyst) is a fluid-filled cyst of the epididymal head containing sperm. Both are common and benign. A Swedish population study reported an annual hydrocele incidence around 60 per 100,000 and a combined hydrocele/spermatocele treatment incidence around 17 per 100,000. Most require no treatment. Intervention - aspiration with sclerotherapy or surgery - is reserved for bothersome size, discomfort, or diagnostic uncertainty. Aspiration/sclerotherapy has notably fewer complications than open surgery (roughly 4.6% vs 17.5% in one series).
The common, benign lumps - the trick is knowing when to leave them alone.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Hydroceles reflect an imbalance between fluid secretion and reabsorption by the tunica vaginalis mesothelium; they may be primary (idiopathic) or secondary to infection, trauma, or tumor. Spermatoceles arise from cystic dilation and obstruction of efferent ductules or epididymal tubules, trapping sperm-laden fluid. Because they occupy the epididymal head, spermatoceles - and especially their surgical removal - can theoretically disrupt sperm transit.
The catch: the surgery, not the cyst, threatens fertility
The fertility caveat is iatrogenic: the lesions themselves rarely impair fertility, but conventional spermatocelectomy can damage the epididymis and cause obstruction on that side, which matters for a man who wants children. This is why microsurgical single-tubule techniques are preferred in men desiring fertility, and why asymptomatic spermatoceles in such men are often simply watched.
When this is an emergency
A soft, transilluminating scrotal swelling (hydrocele) or a discrete cystic lump above and behind the testis (spermatocele). Scrotal ultrasound confirms the fluid nature and, critically, excludes a solid tumor. A hydrocele that does not transilluminate or arises acutely warrants closer evaluation.
What it does to fertility
Both lesions are usually fertility-neutral. The relevant fertility risk is surgical: spermatocelectomy can cause ipsilateral epididymal obstruction. Large tense hydroceles have been speculated to raise scrotal temperature, but a meaningful fertility effect is not established. In men desiring paternity, conservative management and microsurgical technique are favored.
What people get wrong
Often saidA scrotal lump is probably harmless
ActuallyMost are - but the one rule is to image any new solid or non-transilluminating mass to exclude testicular cancer before reassuring the patient.
Often saidRemoving a spermatocele has no downside
ActuallyConventional spermatocelectomy can obstruct the epididymis; in men who want children, a fertility-sparing microsurgical approach or watchful waiting is preferred.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
The people taking it
Adult and older men (hydrocele), and men across adulthood for spermatocele, often found incidentally or during infertility/scrotal evaluation.
What we do not know
- Do large chronic hydroceles measurably impair spermatogenesis via temperature or pressure effects?
- What is the true long-term recurrence rate of aspiration/sclerotherapy versus surgery?
At a glance
- Hydrocele incidence
- ~60 per 100,000 per year (Swedish data)
- Treatment incidence
- ~17 per 100,000 (combined)
- Aspiration+sclerotherapy complications
- ~4.6%
- Open surgery complications
- ~17.5% (RR ~3.8 vs aspiration)
- Fertility-sparing option
- Microsurgical single-tubule spermatocelectomy
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Hydrocele & Spermatocele. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Epidemiology of hydrocele and spermatocele (Scandinavian J Urol)2019
Population incidence, treatment rates, and surgery-vs-aspiration complication data
Aspiration and sclerotherapy series2021
Safe, effective, minimally invasive alternative to surgery